Aiforia Announces Webinar for November 4

Jessica is a 42-year old wife and mother of 2. She was diagnosed with an aggressive form of breast cancer just over seven years ago and doctors recently declared her with no evidence of disease. As a young woman with breast cancer, she became...

NantOmics and NantWork's Machine Vision and Supercomputing Platform to be Combined with OptraSCAN to Provide Next Generation Morphological Visualization of the Tumor Microenvironment and Drive Immunotherapy Clinical Decisions and QUILT clinical...

A pioneering digital histopathology partnership between Sheffield Teaching Hospitals, Hull and East Yorkshire Hospitals and Philips offering a groundbreaking solution to the growing demand for specialist histopathology services at a time when...

Indica Labs would like to formally invite you to our European Quantitative Pathology Meeting in London which will be held on Wednesday 30th November from 12:00 - 5:00 PM at the London Marriott Heathrow Hotel. Indica Labs' customer presenters...

A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study "deeply flawed" and suggest...

Every once in a while there is a headline I just shake my head at, thinking, "how did this research get funded?" This is certainly not the most startling example of this but nonetheless I think most physicians already know this could reject a...